Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Insilico Medicine, Lilly Partner on AI-Driven Drug Discovery Deal
Insilico Medicine and Eli Lilly have entered a partnership to use Insilico’s AI‑driven Pharma.AI platform for discovering new oral therapeutics across several disease areas. Lilly receives an exclusive worldwide license to develop, manufacture and commercialize the preclinical candidates, while Insilico secures a $115 million upfront payment and potential milestones up to $2.75 billion. The collaboration blends Insilico’s computational expertise with Lilly’s development capabilities, establishing joint R&D programs focused on Lilly‑selected targets. Tiered royalties will apply to future sales, aligning long‑term incentives for both parties.
Radiologists Urge Medicare Contractor to Exempt Professional Component From New Pay Restriction
Radiologists, backed by the RBMA and ACR, have asked Noridian Healthcare Solutions to exempt the professional component of CPT 74177 (CT abdomen/pelvis with contrast) and CPT 72148 (MRI spine without contrast) from a new pre‑payment review. Noridian instituted the review citing high...
How Outsourcing Solves the Chronic Shortage of Specialized DME Billing Talent
The durable medical equipment (DME) sector faces a deepening shortage of specialized billing professionals, driven by retirements, high turnover and escalating salary demands. In‑house recruitment struggles to keep pace, leading to longer claim cycles, higher denial rates and financial strain....
New Data Show TrenibotE Safety in Repeat Treatments
Allergan Aesthetics presented new Phase 3 data on its investigational neurotoxin TrenibotE at the 2026 American Academy of Dermatology meeting. The open‑label study evaluated up to three repeat glabellar line treatments, confirming a consistent safety profile, no neutralizing antibodies, rapid onset...
Elidah Reports US FDA Clearance of Elitone for Men to Treat Post-Prostatectomy Urinary Incontinence
Elidah announced that the U.S. Food and Drug Administration has cleared its at‑home device, Elitone for Men, to treat urinary incontinence after prostate surgery. The non‑invasive system delivers neuromuscular stimulation to the pelvic floor for a 20‑minute daily session, eliminating...
Distalmotion Targets ASC Robotic Gynecology Programs with FDA Filing
Distalmotion has filed a 510(k) request to add sacrocolpopexy, sacrocervicopexy and endometriosis resection to the FDA‑cleared indications for its Dexter robotic system. The move targets ambulatory surgical centers, where the robot’s small footprint could out‑compete larger platforms. The company recently...
Kevin Wang, Suki
Kevin Wang, chief medical officer of Suki, discussed the evolution of ambient documentation technology that automates clinical note‑taking and now extends into coding and billing assistance. Suki’s AI‑driven platform is sold directly to providers and embedded in partner solutions such...
The Brave New World of Radiotherapeutics
Radiotherapeutics have moved from niche concepts to a burgeoning oncology platform, driven by unmet treatment gaps and the commercial breakthrough of Novartis' Pluvicto. Early data show Actinium‑225 delivering 45‑50% response rates in heavily pre‑treated prostate cancer, while Bayer's Xofigo adds...
Looking Into the Continuing Costs of India’s COVID-19 Policy
India’s COVID‑19 response left a staggering human toll, with the Registrar General reporting 1.02 crore (≈10.2 million) deaths in 2021—a 25.9% jump over 2020. Three recent books document the pandemic’s clinical, logistical, and personal dimensions, highlighting rail shutdowns, oxygen shortages, and the...
What Disrupts Continuity of Care in Assisted Living Facilities?
Continuity of care is the backbone of assisted‑living operations, linking medical oversight with the emotional stability residents depend on. When care pathways fracture, outcomes such as medication errors, falls, and resident dissatisfaction rise sharply, prompting higher regulatory scrutiny and reputational...
Africa Turns to Philanthropists to Fill Gaps in Health Funding
With international aid shrinking, African governments are turning to philanthropic capital to bridge widening health‑care gaps. The Bill & Melinda Gates Foundation announced a $200 bn spend‑down by 2045, prioritising primary care, data systems and AI‑driven services across the continent. Corporate...
AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure
AskBio, a Bayer subsidiary, announced that enrollment for its GenePHIT Phase 2 trial of the investigational gene therapy AB‑1002 has been completed, randomizing 173 patients with non‑ischemic cardiomyopathy and NYHA Class III heart‑failure symptoms. The trial, spanning 46 sites across North America...
How Rural Health Systems Are Advancing Cardiac Imaging
Rural health systems are deploying cardiac CT scanners to bring high‑resolution, non‑invasive heart imaging to underserved areas. The technology delivers scans in about 15 minutes, enabling clinicians to avoid invasive catheterizations for 77% of patients and cut diagnostic costs by...
Beyond Reimbursement: Why Market Access Is MedTech’s Strategic North Star
The article argues that Market Access (MA) has moved beyond a narrow reimbursement focus to become a strategic engine for MedTech firms. Insights from BCG roundtables and industry leaders highlight new MA capabilities—experts, stewards, and integrators—that drive product adoption, pricing...
HHS Unveils MANA Plan
On April 1, 2026, the U.S. Department of Health and Human Services (HHS) unveiled a new initiative dubbed the MANA plan, short for “Make America Normal Again.” The announcement was delivered by HHS Secretary Robert F. Kennedy Jr. during a briefing at the...
How GLP-1 Is Impacting Food and Beverage Consumption in Australia
GLP-1 receptor agonists, originally developed for type‑2 diabetes, are rapidly being prescribed for weight management in Australia, with about 500,000 users today and projections that 10% of the population could be on the drugs by 2030. Their appetite‑suppressing effect is...
From Data to Discovery: Inside the Bio-IT Hackathon
The Bio‑IT World Hackathon, hosted by the NIH Common Fund Data Ecosystem Training Center, gathered multidisciplinary teams to tackle six real‑world biomedical data challenges using cloud‑based AI tools. Participants, ranging from students to industry professionals, had 48 hours to develop...
University of Toledo Health to Deploy Nabla’s Ambient AI Documentation in Epic EHR
University of Toledo Health is rolling out Nabla’s ambient AI clinical assistant to hundreds of physicians and advanced practice providers, embedding the technology directly into Epic’s electronic health record. The AI listens to doctor‑patient conversations and auto‑generates structured notes, cutting...
What Does It Mean To Be ‘California Sober’?
The "California sober" approach promotes swapping high‑risk substances such as alcohol, opioids, or stimulants for moderate cannabis use, positioning itself as a harm‑reduction alternative to total abstinence. Proponents cite greater control, smoother withdrawal, and improved daily functioning, while critics warn...
The Role of Ethical Oversight and Algorithmic Bias in Automated Pharmacovigilance
Pharmacovigilance is rapidly adopting machine learning, natural language processing, and automation to ingest, categorize, and prioritize adverse event reports, dramatically shrinking backlogs and accelerating signal detection. While these technologies deliver speed and scale, they also inherit reporting biases and can...
Skipping Power Training Increases Death Risk Sixfold
What’s more dangerous than doing power work? Not doing it. A 2025 study of 3,889 people found those with the lowest muscle power had a nearly 6x higher risk of death than the highest group. Slow training builds slow people. Slow people die...
Wegovy to Reach 1.2 Million Additional NHS Patients
Novo Nordisk $NVO obesity drug Wegovy will be an option for about 1.2 million more patients in England’s National Health Service - Bloomberg
Philips Issues Urgent Device Correction Notice for Thousands of Imaging Units
Philips Healthcare has issued an urgent correction notice for its Allura and Azurion interventional fluoroscopy systems after discovering a foot‑switch design flaw that can prevent or intermittently enable X‑ray imaging. The U.S. FDA classified the issue as a Class 2 recall,...
Study's COVID Vaccine Benefits Limited to Early Pandemic
This tweet and accompanying paper are fairly misleading (note: paper is from July ‘24) There are many issues w the study itself that it’s a bit tough to go into here. But most importantly, the paper concludes: “Our findings support the...
Support MOTAvation: Walk, Donate, Save Lives
- Join Team MOTAvation - Walk with us, support us, or donate - Help fund the research and care that saves lives https://t.co/0lRU8JoEpo
Rights Group Report Identifies Alternatives to Mental Health Crisis Response in US
Human Rights Watch released a report identifying 150 non‑police mental‑health crisis programs across the United States, with eight detailed case studies such as Oakland’s Mobile Assistance Community Responders and Cambridge’s Holistic Emergency Alternative Response Team. The report finds that removing...
Discrete OTC Hearing Aids: Flysound H8 vs H9 Review
Can't hear everyone in a meeting or while at the sports bar? Might be time to consider a discrete hearing aid. I check out two, the Flysound Premium OTC Hearing Aids Models H8 & H9. Same tech, different designs: https://t.co/1J3G3Zm7U4...
:max_bytes(150000):strip_icc():format(jpeg)/zoloft-overdose-1067483_final-f8bf664ae4ac495eab04b736c0c00ed1.png)
Symptoms of a Zoloft Overdose
Zoloft (sertraline) overdoses can produce a spectrum of symptoms from mild dizziness and nausea to severe serotonin syndrome, seizures, and cardiac issues. The article emphasizes immediate contact with the national Poison Control hotline (1‑800‑222‑1222) and outlines emergency interventions such as...
NUS Unveils Wearable Sensor That Boosts Fatigue Detection Accuracy to 93%
Researchers at the National University of Singapore have introduced a hydrogel‑based wearable that lifts peak‑detection accuracy for fatigue from 52% to 93% and achieves a 37 dB signal‑to‑noise ratio during movement. The device, called the metahydrogel artefact‑mitigating platform (MAP), combines material...
Coventry Rolls Out 24/7 Text‑Based Mental‑Health Service, Boosting Mindfulness Access
Coventry and Warwickshire Partnership NHS Trust, together with charity Mental Health Innovations, launched a free 24/7 text‑messaging service that connects callers with trained mental‑health professionals. The service, already handling about 5,000 daily contacts, aims to ease pressure on NHS 111...
Sen. Tammy Baldwin Urges Defense Health Agency to Probe Delayed TBI Care for Iran‑war Soldiers
Sen. Tammy Baldwin has written to the Defense Health Agency, demanding an investigation into delayed medical care for soldiers wounded in the March 1 Iran‑related drone attack. She cites at least two Wisconsin reservists facing weeks‑long waits for neurologist appointments...
New Hampshire’s Secret Role in Northeast Public Health Data Consortium Raises Transparency Concerns
New Hampshire officials have been quietly involved in the Northeast Public Health Collaborative since its inception, even though the state was omitted from the public announcement. Internal emails reveal the state’s continued participation in leadership calls and data‑sharing initiatives, highlighting...
Lantern Pharma Narrows Q4 Loss, Schedules FDA Type C Meeting for LP‑300 in May 2026
Lantern Pharma Inc. posted a narrower fourth‑quarter net loss and saw its stock rise 26.3% to $1.56. The company also confirmed a mid‑May 2026 FDA Type C meeting for LP‑300, its phase‑2 lung‑cancer therapy, underscoring a pivotal regulatory milestone for...
Scholar Rock’s Apitegromab BLA Resubmission Boosts Stock 11% in Pre‑Market
Scholar Rock Holding Corp. resubmitted its Biologics License Application for apitegromab to the FDA, adding a second U.S. fill‑finish site to secure supply. The move lifted the shares about 11% in early trading and positions the company for a PDUFA...
Eli Lilly to Acquire Centessa in $7.8 B Deal, Stock Jumps 45%
Eli Lilly agreed to buy Centessa Pharmaceuticals for up to $7.8 billion, paying $38 per share in cash plus a contingent value right worth up to $9 per share. The announcement lifted Centessa’s Nasdaq price 45% to a 52‑week high, underscoring...
Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs
April’s healthcare talent roundup shows a wave of tech‑savvy hires, with Advocate Health tapping a former Verily chief and Artera appointing an ex‑Amazon CTO. Cigna announced its long‑time COO Brian Evanko will take over as CEO, while several seasoned leaders...
Nihon PMI Partners on Tapping Into Japan’s Home-Based Healthcare Market
Nihon PMI Partners announced a strategic push into Japan’s rapidly expanding home‑based healthcare sector. CEO Satoshi Hamada highlighted that the nation’s aging population and a policy‑driven shift from hospital to community care are creating sizable investment openings. The firm plans...
Swallowable AI Capsule Diagnoses Digestive Issues in Minutes
Swallowable #AI Capsule Can Diagnose Digestive Issues in Minutes by @China_Amb_India #MedTech #HealthTech #Tech #Technology #EmergingTech #TechForGood https://t.co/AAR1YthCd3
Jimini Health Raises $17 Million to Expand AI‑Driven Mental‑Health Chatbot
Jimini Health announced a $17 million seed round to accelerate its AI‑driven mental‑health chatbot, Sage. Backed by investors such as M13 and Town Hall Ventures, the funding will help the startup embed clinician‑supervised AI into large behavioral‑health systems, signaling a new...
Lancet Study Shows Fortified Foods Prevent 7 Billion Nutrient Gaps, Could Triple Impact
A Lancet Global Health study led by the Global Alliance for Improved Nutrition (GAIN) reports that current large‑scale food fortification prevents nearly 7 billion micronutrient gaps each year at a cost of $0.18 per person. Researchers say expanding programs could triple...
UK Tightens EYFS Safer‑Sleep Rules After Tragic Infant Death
Early education minister Olivia Bailey has announced amendments to the EYFS statutory framework that embed stricter safer‑sleep requirements, a move prompted by the 2022 death of nine‑month‑old Genevieve Meehan. The changes, slated for September, shift guidance from NHS references into...
Study Finds 20% of Australian Maternal Deaths Within Five Years Are Preventable
A new analysis of more than 1.7 million live births in New South Wales reveals that 20% of maternal deaths occurring within five years of childbirth could have been avoided. The study, led by Dr Louise Makarious, points to suicide, accidental poisoning...
Gerontologist Aubrey De Grey Says Medicine Could Outpace Aging Within Two Decades
Aubrey de Grey, founder and CSO of the Longevity Escape Velocity Foundation, told listeners of Longevity Technology Unlocked that emerging therapies could rejuvenate people in their 60s back to a biological age of 40, buying roughly 20 years for further...
Agios Pursues Accelerated FDA Approval for Mitapivat as Sickle‑Cell Therapy, Shares Jump 21%
Agios Pharmaceuticals announced it will seek accelerated U.S. approval for its oral drug mitapivat to treat sickle‑cell disease, prompting a 21.7% rise in its shares. The company has already filed a confirmatory trial proposal with the FDA and is preparing...
Announcing NIHI – McMaster Spring Courses
The National Institutes of Health Informatics (NIHI) and McMaster University Continuing Education are launching a series of micro‑courses for healthcare professionals in spring 2026. Two flagship offerings are "Leadership in Health Care: Change Leadership" (April 15‑June 10) and "Effective Dashboards for Health...
Partners Aim to Improve Remote Monitoring
CHAH AI Care and Quoted Tech have formed a strategic partnership to launch the CHAD AI Support Hub, an AI‑powered remote monitoring system for seniors and medically complex patients in Canada. The first batch of 50 hubs will be deployed...
How Your Health (and Genetic Results) Affects Your Life, Travel and Health Insurance
The Australian Parliament is set to pass legislation that will prohibit life insurers from using predictive genetic test results in underwriting, taking effect in about six months for all new life‑insurance contracts. The ban covers death, income protection, disability and...
6 UK Hospitals Partner with SickKids AI Program
Six leading UK NHS paediatric hospitals have signed a memorandum of understanding with Toronto’s Hospital for Sick Children to join its SKAI artificial intelligence program. The partnership creates a two‑way exchange of AI models, expertise, and clinical training aimed at...
Hawkesbury Conducts Surgery with J&J Robot
Hawkesbury and District General Hospital performed its first surgery using Johnson & Johnson’s VELYS Robotic‑Assisted Solution, led by orthopedic surgeon Dr. Simon Garceau. The system delivers millimetre‑level precision, which can lessen tissue trauma, postoperative pain and inflammation. Hospital executives highlighted...
$5M Gift to UHN Supports Cancer Care
Bank of Montreal (BMO) has pledged a $5 million CAD (approximately $3.7 million USD) donation to University Health Network (UHN) to fund the new Surgical Tower at Toronto Western Hospital and expand PMATCH, an AI‑driven precision‑oncology platform at Princess Margaret Cancer Centre....